Facial Plast Surg 2018; 34(06): 631-640
DOI: 10.1055/s-0038-1660845
Rapid Communication
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Platelet-Rich Plasma for the Treatment of Androgenic Alopecia: A Systematic Review

Jenny X. Chen
1   Department of Otolaryngology, Massachusetts Eye and Ear, Boston, Massachusetts
,
Natalie Justicz
1   Department of Otolaryngology, Massachusetts Eye and Ear, Boston, Massachusetts
,
Linda N. Lee
1   Department of Otolaryngology, Massachusetts Eye and Ear, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
28 June 2018 (online)

Abstract

The use of platelet-rich plasma (PRP) has become increasingly commonplace in facial plastic surgery for the treatment of androgenic alopecia (AGA). However, this treatment remains novel with a range of application techniques and outcomes described in the literature. Herein, the authors systematically review the existing literature on the use and efficacy of PRP for AGA. Systematic review of PubMed, Embase, and Cochrane databases was performed. Case reports were excluded. Twenty-four papers met inclusion criteria for this study: 8 randomized control trials and 16 prospective cohort studies. Twenty-one studies used clinical criteria to diagnose AGA, while three used confirmatory biopsies. PRP was injected with or without the use of a numbing agent, and most studies performed multiple injections (three or more separated by several weeks). Twenty-one studies reported positive outcomes by objective criteria (88%), while three suggested that there was no clinical improvement, although in two of these studies patients still reported increased satisfaction. There were no complications reported other than transient edema/erythema and pain/headache associated with the procedure. The existing literature suggests that PRP is a low-risk intervention to treat AGA associated with good patient satisfaction and objective improvements in outcomes. Further research is needed to optimize preparation and delivery methods as well as standardize measurements of clinical outcomes.

 
  • References

  • 1 Hamilton JB. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 1951; 53 (03) 708-728
  • 2 Gan DCC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc 2005; 10 (03) 184-189
  • 3 Krupa Shankar D, Chakravarthi M, Shilpakar R. Male androgenetic alopecia: population-based study in 1,005 subjects. Int J Trichology 2009; 1 (02) 131-133
  • 4 Tabolli S, Sampogna F, di Pietro C, Mannooranparampil TJ, Ribuffo M, Abeni D. Health status, coping strategies, and alexithymia in subjects with androgenetic alopecia: a questionnaire study. Am J Clin Dermatol 2013; 14 (02) 139-145
  • 5 Bater KL, Ishii M, Joseph A, Su P, Nellis J, Ishii LE. Perception of hair transplant for androgenetic alopecia. JAMA Facial Plast Surg 2016; 18 (06) 413-418
  • 6 Bernstein RM, Rassman WR. Follicular transplantation. Patient evaluation and surgical planning. Dermatol Surg 1997; 23 (09) 771-784 , discussion 801–805
  • 7 Harris JA. Follicular unit extraction. Facial Plast Surg Clin North Am 2013; 21 (03) 375-384
  • 8 Beitzel K, Allen D, Apostolakos J. , et al. US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine. J Knee Surg 2015; 28 (01) 29-34
  • 9 Ulusal BG. Platelet-rich plasma and hyaluronic acid - an efficient biostimulation method for face rejuvenation. J Cosmet Dermatol 2017; 16 (01) 112-119
  • 10 Asif M, Kanodia S, Singh K. Combined autologous platelet-rich plasma with microneedling verses microneedling with distilled water in the treatment of atrophic acne scars: a concurrent split-face study. J Cosmet Dermatol 2016; 15 (04) 434-443
  • 11 Shin M-K, Lee J-H, Lee S-J, Kim N-I. Platelet-rich plasma combined with fractional laser therapy for skin rejuvenation. Dermatol Surg 2012; 38 (04) 623-630
  • 12 Kang J-S, Zheng Z, Choi MJ, Lee S-H, Kim D-Y, Cho SB. The effect of CD34+ cell-containing autologous platelet-rich plasma injection on pattern hair loss: a preliminary study. J Eur Acad Dermatol Venereol 2014; 28 (01) 72-79
  • 13 Sclafani AP, Azzi J. Platelet preparations for use in facial rejuvenation and wound healing: a critical review of current literature. Aesthetic Plast Surg 2015; 39 (04) 495-505
  • 14 Moher D, Shamseer L, Clarke M. , et al; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4: 1-9
  • 15 Anitua E, Pino A, Martinez N, Orive G, Berridi D. The effect of plasma rich in growth factors on pattern hair loss: a pilot study. Dermatol Surg 2017; 43 (05) 658-670
  • 16 Jha AK, Udayan UK, Roy PK, Amar AKJ, Chaudhary RKP. Original article: Platelet-rich plasma with microneedling in androgenetic alopecia along with dermoscopic pre- and post-treatment evaluation. J Cosmet Dermatol 2017; 17 (09) 313-318
  • 17 Kachhawa D, Vats G, Sonare D, Rao P, Khuraiya S, Kataiya R. A spilt head study of efficacy of placebo versus platelet-rich plasma injections in the treatment of androgenic alopecia. J Cutan Aesthet Surg 2017; 10 (02) 86-89
  • 18 James R, Chetry R, Subramanian V. , et al. Platelet-rich plasma growth factor concentrated spray (Keratogrow®) as a potential treatment for androgenic alopecia. J Stem Cells 2016; 11 (04) 183-189
  • 19 James R, Chetry R, Subramanian V. , et al. Efficacy of activated 3x platelet-rich plasma in the treatment of androgenic alopecia. J Stem Cells 2016; 11 (04) 191-199
  • 20 Rodrigues BL, Montalvão SADL, Annichinno-Bizzacchi J. , et al. The therapeutic response of platelet rich plasma (PRP) for androgenetic alopecia showed no correlation with growth factors and platelet number. Blood 2016; 128 (22) 2637-2637
  • 21 Borhan R, Gasnier C, Reygagne P. Autologous platelet rich plasma as a treatment of male androgenetic alopecia: study of 14 cases. J Clin Exp Dermatol Res 2015; 6 (04) 1-6
  • 22 Singhal P, Agarwal S, Dhot PS, Sayal SK. Efficacy of platelet-rich plasma in treatment of androgenic alopecia. Asian J Transfus Sci 2015; 9 (02) 159-162
  • 23 Gkini M-A, Kouskoukis A-E, Tripsianis G, Rigopoulos D, Kouskoukis K. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg 2014; 7 (04) 213-219
  • 24 Khatu SS, More YE, Gokhale NR, Chavhan DC, Bendsure N. Platelet-rich plasma in androgenic alopecia: myth or an effective tool. J Cutan Aesthet Surg 2014; 7 (02) 107-110
  • 25 Marwah M, Godse K, Patil S, Nadkarni N. Is there sufficient research data to use platelet-rich plasma in dermatology?. Int J Trichology 2014; 6 (01) 35-36
  • 26 Sclafani AP. Platelet-rich fibrin matrix (PRFM) for androgenetic alopecia. Facial Plast Surg 2014; 30 (02) 219-224
  • 27 Betsi E-E, Germain E, Kalbermatten DF, Tremp M, Emmenegger V. Platelet-rich plasma injection is effective and safe for the treatment of alopecia. Eur J Plast Surg 2013; 36 (07) 407-412
  • 28 Takikawa M, Nakamura S, Nakamura S. , et al. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg 2011; 37 (12) 1721-1729
  • 29 Greco J, Brandt R. The effects of autologous platelet rich plasma and various growth factors on non-transplanted miniaturized hair. Hair Transpl Forum Int 2009; 19: 49-50
  • 30 Gentile P, Cole JP, Cole MA. , et al. Evaluation of not-activated and activated PRP in hair loss treatment: role of growth factor and cytokine concentrations obtained by different collection systems. Int J Mol Sci 2017; 18 (02) E408s
  • 31 Puig CJ, Reese R, Peters M. Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia. Dermatol Surg 2016; 42 (11) 1243-1247
  • 32 Gentile P, Garcovich S, Bielli A, Scioli MG, Orlandi A, Cervelli V. The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial. Stem Cells Transl Med 2015; 4 (11) 1317-1323
  • 33 Farid CI, Abdelmaksoud RA. Platelet-rich plasma microneedling versus 5% topical minoxidil in the treatment of patterned hair loss. J Egypt Women's Dermatol Soc 2016; 13 (01) 29-36
  • 34 Tawfik AA, Osman MAR. The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: a randomized placebo-controlled study. J Cosmet Dermatol 2018; 17 (01) 47-53
  • 35 Alves R, Grimalt R. Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia. Dermatol Surg 2016; 42 (04) 491-497
  • 36 Cervelli V, Garcovich S, Bielli A. , et al. The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. BioMed Res Int 2014; 2014: 760709
  • 37 Kang R, Nimmons GL, Drennan W. , et al. Development and validation of the University of Washington Clinical Assessment of Music Perception test. Ear Hear 2009; 30 (04) 411-418
  • 38 Mapar MA, Shahriari S, Haghighizadeh MH. Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: a pilot randomized controlled trial. J Cosmet Laser Ther 2016; 18 (08) 452-455
  • 39 Gupta AK, Carviel JL. Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia. J Dermatolog Treat 2017; 28 (01) 55-58
  • 40 Schiavone G, Raskovic D, Greco J, Abeni D. Platelet-rich plasma for androgenetic alopecia: a pilot study. Dermatol Surg 2014; 40 (09) 1010-1019
  • 41 Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009; 27 (03) 158-167
  • 42 Gupta AK, Carviel J. A mechanistic model of platelet-rich plasma treatment for androgenetic alopecia. Dermatol Surg 2016; 42 (12) 1335-1339